Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
AUTOR(ES)
Parkes, J. D.
RESUMO
Fourteen slightly disabled patients with Parkinsonism were treated separately with benzhexol, amantadine, and levodopa. Benzhexol and amantadine both gave a 15% reduction in functional disability and levodopa a 36% reduction. Benzhexol lessened the rigidity and improved the flexion of posture of Parkinson's disease, but had little or no effect on akinesia and tremor. Amantadine and levodopa caused improvement in all these symptoms. The combination of benzhexol and amantadine was as effective after four weeks of treatment as levodopa was after six months.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=494673Documentos Relacionados
- Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease
- Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.
- Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
- Levodopa‐induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
- Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
